Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EvexiPEL, a brand under EVEXIAS Health Solutions, is a leading provider of bioidentical hormone replacement therapy (BHRT) specializing in pellet delivery systems. The company offers a comprehensive approach to hormone optimization through its proprietary EvexiPEL Method, which includes practitioner training, advanced dosing technology, and high-quality compounded pellets. Their services target the root causes of symptoms related to hormonal imbalance, such as fatigue, brain fog, and decreased libido, primarily in aging populations. In addition to hormone therapy, EvexiPEL provides integrated wellness solutions, including pharmaceutical-grade nutraceuticals. The company operates through a large network of certified medical providers across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EvexiPEL.